ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 129 filers reported holding ANIKA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15,640 | -17.0% | 602 | -8.2% | 0.00% | – |
| Q1 2023 | $18,840 | -99.3% | 656 | -99.2% | 0.00% | -100.0% |
| Q4 2022 | $2,571,587 | +11.0% | 86,878 | -10.7% | 0.01% | 0.0% |
| Q3 2022 | $2,316,000 | -1.0% | 97,341 | -7.2% | 0.01% | 0.0% |
| Q2 2022 | $2,339,000 | -8.3% | 104,841 | +3.1% | 0.01% | +25.0% |
| Q1 2022 | $2,551,000 | -33.7% | 101,641 | -5.4% | 0.00% | -33.3% |
| Q4 2021 | $3,848,000 | -23.6% | 107,464 | -9.2% | 0.01% | -33.3% |
| Q3 2021 | $5,037,000 | -17.4% | 118,396 | -15.9% | 0.01% | -10.0% |
| Q2 2021 | $6,095,000 | -41.0% | 140,841 | -44.4% | 0.01% | -44.4% |
| Q1 2021 | $10,325,000 | +10.5% | 253,189 | +22.6% | 0.02% | 0.0% |
| Q4 2020 | $9,341,000 | +88.4% | 206,461 | +47.2% | 0.02% | +63.6% |
| Q3 2020 | $4,959,000 | +24.4% | 140,225 | +29.1% | 0.01% | +22.2% |
| Q2 2020 | $3,985,000 | +137.3% | 108,598 | +84.8% | 0.01% | +125.0% |
| Q1 2020 | $1,679,000 | -38.3% | 58,754 | +12.4% | 0.00% | -20.0% |
| Q4 2019 | $2,720,000 | +41.2% | 52,285 | +48.4% | 0.01% | +25.0% |
| Q3 2019 | $1,926,000 | +83.6% | 35,243 | +35.5% | 0.00% | +100.0% |
| Q2 2019 | $1,049,000 | -0.6% | 26,004 | -25.5% | 0.00% | 0.0% |
| Q1 2019 | $1,055,000 | +9.2% | 34,896 | +21.5% | 0.00% | 0.0% |
| Q4 2018 | $966,000 | -58.7% | 28,727 | -48.2% | 0.00% | -50.0% |
| Q3 2018 | $2,340,000 | +84.7% | 55,470 | +40.0% | 0.00% | +33.3% |
| Q2 2018 | $1,267,000 | -44.1% | 39,617 | -13.0% | 0.00% | -25.0% |
| Q1 2018 | $2,265,000 | -20.6% | 45,558 | -14.7% | 0.00% | -20.0% |
| Q4 2017 | $2,851,000 | +12.1% | 53,405 | +21.8% | 0.01% | +25.0% |
| Q3 2017 | $2,544,000 | +2.1% | 43,860 | -13.2% | 0.00% | 0.0% |
| Q2 2017 | $2,492,000 | -8.4% | 50,507 | -19.3% | 0.00% | -20.0% |
| Q1 2017 | $2,720,000 | -50.8% | 62,607 | -44.3% | 0.01% | -54.5% |
| Q4 2016 | $5,532,000 | – | 112,480 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trigran Investments, Inc. | 1,154,183 | $25,761,000 | 3.00% |
| CAPITAL MANAGEMENT CORP /VA | 275,130 | $6,141,000 | 1.52% |
| Kent Lake Capital LLC | 98,570 | $2,200,000 | 1.21% |
| DIKER MANAGEMENT LLC | 21,835 | $487,000 | 0.60% |
| Portolan Capital Management | 235,972 | $5,267,000 | 0.53% |
| Riverwater Partners LLC | 12,466 | $278,000 | 0.28% |
| Ranger Investment Management | 139,661 | $3,117,000 | 0.24% |
| Invenomic Capital Management LP | 144,287 | $3,220,000 | 0.23% |
| CHATHAM CAPITAL GROUP, INC. | 23,787 | $531,000 | 0.12% |
| Teton Advisors, Inc. | 22,000 | $491,000 | 0.10% |